Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Schibsted in conjunction with investment in Savr
Mandate

Vinge advises Schibsted in conjunction with investment in Savr

March 08, 2022 M&A Banking and Finance Intellectual Property

Vinge has advised Schibsted in conjunction with its investment in Savr AB. The investment round, which is headed by Schibsted, will cotribute SEK 162 million to the company. Savr is a fund platform which repays all fund commission to its customers.

Vinge’s team consisted primarily of Johan Winnerblad, Emma Stuart-Beck, Henrik Schön, Caroline Krassén, Anton Sjökvist and Sofia Bergenstråhle.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026